RxDoctor Payments DataLook up a doctor →

Laura Kinney, MD

Internal Medicine · Charleston, SCNPI 1386609931

Payments from drug & device makers

$19,566in general payments, 2019–2025

Across 1,090 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$2K
  • Johnson & Johnson$1K
  • Amgen$932
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)166$2,156
Novo Nordisk127$2,007
AstraZeneca67$1,612
Lilly USA, LLC76$1,520
Johnson & Johnson37$1,186
Amgen(2 entities)63$932
Bayer51$905
Pfizer50$858
Boehringer Ingelheim43$790
GSK37$669
Exact Sciences20$497
Sumitomo Pharma America, Inc.18$436
Esperion Therapeutics, Inc.25$415
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$399
Merck25$331
Sunovion Pharmaceuticals Inc.18$316
Novartis14$279
Takeda Pharmaceuticals U.S.A., Inc.12$268
Astellas Pharma US Inc10$258
Otsuka America Pharmaceutical, Inc.10$202
Supernus Pharmaceuticals, Inc.5$187
Amarin Pharma, Inc.12$186
Boston Scientific8$180
Paratek Pharmaceuticals, Inc.9$175
Bausch Health US, LLC7$170
Neos Therapeutics, LP26$163
Alnylam Pharmaceuticals Inc.8$159
Avanir Pharmaceuticals, Inc.9$154
Currax Pharmaceuticals LLC10$144
Shield Therapeutics Inc6$122
Biohaven Pharmaceutical Holding Company Ltd.6$121
Axsome Therapeutics, Inc.5$112
Corium, LLC5$110
Abbott5$109
Amneal Pharmaceuticals LLC5$98
Harmony Biosciences LLC5$95
E.r. Squibb & Sons, L.L.C.6$94
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$94
Lundbeck LLC5$90
Eisai Inc.6$90
Averitas Pharma Inc.1$69
Phathom Pharmaceuticals, Inc.3$67
Biohaven Pharmaceuticals, Inc.3$66
Corcept Therapeutics3$63
Sanofi-aventis U.S. LLC4$63
Teva Pharmaceuticals USA, Inc.4$50
Vivus LLC3$49
Shire North American Group Inc3$45
Kowa Pharmaceuticals America, Inc.3$37
Idorsia Pharmaceuticals US Inc2$34
Arbor Pharmaceuticals, Inc.2$31
Medtronic1$29
Almatica Pharma LLC2$28
Seqirus USA Inc1$27
Edwards Lifesciences1$24
Nabriva Therapeutics, PLC1$23
Jazz Pharmaceuticals Inc.1$23
Alfasigma USA, Inc.1$21
Hikma Pharmaceuticals USA1$21
C2n Diagnostics, LLC1$20

How this compares

$19,566 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$323,885
Medicare patients
787
Services billed
8,241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →